795 related articles for article (PubMed ID: 32530972)
1. Outcomes of HIV-positive patients with non-tuberculous mycobacteria positive culture who received anti-tuberculous treatment in Botswana: Implications of using diagnostic algorithms without non-tuberculous mycobacteria.
Agizew T; Boyd R; Mathebula U; Mathoma A; Basotli J; Serumola C; Pals S; Finlay A; Lekone P; Rankgoane-Pono G; Tlhakanelo T; Chihota V; Auld AF
PLoS One; 2020; 15(6):e0234646. PubMed ID: 32530972
[TBL] [Abstract][Full Text] [Related]
2. Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay.
Agizew T; Basotli J; Alexander H; Boyd R; Letsibogo G; Auld A; Nyirenda S; Tedla Z; Mathoma A; Mathebula U; Pals S; Date A; Finlay A
PLoS One; 2017; 12(12):e0189981. PubMed ID: 29272273
[TBL] [Abstract][Full Text] [Related]
3. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial.
Agizew T; Chihota V; Nyirenda S; Tedla Z; Auld AF; Mathebula U; Mathoma A; Boyd R; Date A; Pals SL; Lekone P; Finlay A
BMC Infect Dis; 2019 Dec; 19(1):1058. PubMed ID: 31842773
[TBL] [Abstract][Full Text] [Related]
4. Tuberculosis and non-tuberculous mycobacteria among HIV-infected individuals in Ghana.
Bjerrum S; Oliver-Commey J; Kenu E; Lartey M; Newman MJ; Addo KK; Hilleman D; Andersen AB; Johansen IS
Trop Med Int Health; 2016 Sep; 21(9):1181-90. PubMed ID: 27383726
[TBL] [Abstract][Full Text] [Related]
5. [A study of the value of three molecular diagnostic techniques in the diagnosis of tuberculosis].
Huang F; Dang L; Sun H; Yang H; Wu X
Zhonghua Jie He He Hu Xi Za Zhi; 2015 Sep; 38(9):680-5. PubMed ID: 26703773
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis Case Finding With Combined Rapid Point-of-Care Assays (Xpert MTB/RIF and Determine TB LAM) in HIV-Positive Individuals Starting Antiretroviral Therapy in Mozambique.
Floridia M; Ciccacci F; Andreotti M; Hassane A; Sidumo Z; Magid NA; Sotomane H; David M; Mutemba E; Cebola J; Mugunhe RJ; Riccardi F; Marazzi MC; Giuliano M; Palombi L; Mancinelli S
Clin Infect Dis; 2017 Nov; 65(11):1878-1883. PubMed ID: 29020319
[TBL] [Abstract][Full Text] [Related]
7. Of tuberculosis and non-tuberculous mycobacterial infections - a comparative analysis of epidemiology, diagnosis and treatment.
Gopalaswamy R; Shanmugam S; Mondal R; Subbian S
J Biomed Sci; 2020 Jun; 27(1):74. PubMed ID: 32552732
[TBL] [Abstract][Full Text] [Related]
8. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G
PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
[TBL] [Abstract][Full Text] [Related]
10. Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting.
Rice JP; Seifert M; Moser KS; Rodwell TC
PLoS One; 2017; 12(10):e0186139. PubMed ID: 29016684
[TBL] [Abstract][Full Text] [Related]
11. Cost Analysis of Tuberculosis Diagnosis in Cambodia with and without Xpert
Pallas SW; Courey M; Hy C; Killam WP; Warren D; Moore B
Appl Health Econ Health Policy; 2018 Aug; 16(4):537-548. PubMed ID: 29862440
[TBL] [Abstract][Full Text] [Related]
12. Intensified tuberculosis case finding among HIV-infected persons using a WHO symptom screen and Xpert(®) MTB/RIF.
Adelman MW; Tsegaye M; Kempker RR; Alebachew T; Haile K; Tesfaye A; Aseffa A; Blumberg HM
Int J Tuberc Lung Dis; 2015 Oct; 19(10):1197-203. PubMed ID: 26459533
[TBL] [Abstract][Full Text] [Related]
13. Implementation of a pragmatic, stepped-wedge cluster randomized trial to evaluate impact of Botswana's Xpert MTB/RIF diagnostic algorithm on TB diagnostic sensitivity and early antiretroviral therapy mortality.
Auld AF; Agizew T; Pals S; Finlay A; Ndwapi N; Boyd R; Alexander H; Mathoma A; Basotli J; Gwebe-Nyirenda S; Shepherd J; Ellerbrock TV; Date A
BMC Infect Dis; 2016 Oct; 16(1):606. PubMed ID: 27782821
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of a clinical diagnostic algorithm for management of ambulatory smear and Xpert MTB/Rif negative HIV infected patients with presumptive pulmonary TB in Uganda: a prospective study.
Walusimbi S; Semitala F; Bwanga F; Haile M; De Costa A; Davis L; Joloba M; Hoffner S; Kamya M
Pan Afr Med J; 2016; 23():154. PubMed ID: 27303572
[TBL] [Abstract][Full Text] [Related]
15. Light-emitting diode fluorescent microscopy and Xpert MTB/RIF® assay for diagnosis of pulmonary tuberculosis among patients attending Ambo hospital, west-central Ethiopia.
Gelalcha AG; Kebede A; Mamo H
BMC Infect Dis; 2017 Sep; 17(1):613. PubMed ID: 28893193
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis in people newly diagnosed with HIV at a large HIV care and treatment center in Northwest Cameroon: Burden, comparative screening and diagnostic yields, and patient outcomes.
Mbu ET; Sauter F; Zoufaly A; Bronsvoort BMC; Morgan KL; Noeske J; Abena JF; Sander MS
PLoS One; 2018; 13(6):e0199634. PubMed ID: 29944701
[TBL] [Abstract][Full Text] [Related]
17. Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts.
Kawasaki M; Echiverri C; Raymond L; Cadena E; Reside E; Gler MT; Oda T; Ito R; Higashiyama R; Katsuragi K; Liu Y
PLoS Med; 2019 Apr; 16(4):e1002780. PubMed ID: 30978194
[TBL] [Abstract][Full Text] [Related]
18. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.
Tesfaye A; Fiseha D; Assefa D; Klinkenberg E; Balanco S; Langley I
BMC Infect Dis; 2017 May; 17(1):318. PubMed ID: 28464797
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Xpert MTB/RIF assay for diagnosis of tuberculosis and rifampin resistance in county-level laboratories in Hunan province, China.
Hu P; Bai L; Liu F; Ou X; Zhang Z; Yi S; Chen Z; Gong D; Liu B; Guo J; Tan Y
Chin Med J (Engl); 2014; 127(21):3744-50. PubMed ID: 25382330
[TBL] [Abstract][Full Text] [Related]
20. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
